A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin

References

• Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin. 2000;18:91–98.
   PubMed Web of Science ®Google Scholar
• Naito SK. Fractional photothermolysis treatment for resistant melasma in Chinese females. J Cosmet Laser Ther. 2007; 9:161–163.
   PubMedGoogle Scholar
• Pawaskar MD, Parikh P, Markowski T, McMichael AJ, Feldman SR, Balkrishnan R. Melasma and its impact on health related quality of life in Hispanic women. J Dermatol Treat. 2007;18:5–9.
   PubMed Web of Science ®Google Scholar
• Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010;36:76–87.
   PubMed Web of Science ®Google Scholar
• Zhou X, Gold MH, Lu Z, Li Y. Efficacy and safety of Q-switched 1,064 nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Dermatol Surg. 2011;37:962–970.
   PubMed Web of Science ®Google Scholar
• Brown AS, Hussain M, Goldberg DJ. Treatment of melasma with low fluence, large post size, 1064 nm Q-switched neodymium-doped yttrium aluminum garnet (Nd: YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV. J Cosmet Laser Ther. 2011;13:280–282.
   PubMed Web of Science ®Google Scholar
• Hong SP, Han SS, Choi SJ, Kim MS, Won CH, Lee MW, et al. Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin. J Cosmet Laser Ther. 2012;14:81–86.
   PubMed Web of Science ®Google Scholar
• Kroon MW, Wind BS, Beek JF, van der Veen JP, Nieuweboer-Krobotova L, Bos JD, Wolkerstorfer A. Nonablative 1550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study. J Am Acad Dermatol. 2011;64:516–523.
   PubMed Web of Science ®Google Scholar
• Park JM, Tsao H, Tsao S. Combined use of intense pulsed light and Q-switched ruby laser for complex dyspigmentation among Asian patients. Lasers Surg Med. 2008;40:128–133.
   PubMed Web of Science ®Google Scholar
• Polnikorn N. Treatment of refractory melasma with the MedLite C6 Q-switched Nd: YAG laser and alpha arbutin: a prospective study. J Cosmet Laser Ther. 2010;12:126–131.
   PubMed Web of Science ®Google Scholar
• Park KY, Kim DH, Kim HK, Li K, Seo SJ, Hong CK. A randomized, observer-blinded, comparison of combined 1064 nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs laser monotherapy to treat melasma. Clin Exp Dermatol. 2011;36:864–870.
   PubMed Web of Science ®Google Scholar
• Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, et al. Reliability assessment and validation of the malsma area and severity index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol. 2011;64: 78–83.
   PubMed Web of Science ®Google Scholar
• Suh KS, Sung JY, Roh JH, Jeon YS, Kim YC, Kim ST. Efficacy of the 1064 nm Q-switched Nd: YAG laser in melasma. J Dermatolog Treat. 2011;22:233–238.
   PubMed Web of Science ®Google Scholar
• Mun JY, Jeong SY, Kim JH, Han SS, Kim IH. A low fluence Q-switched Nd: YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J electron Microsc (Tokyo). 2011; 60:11–18.
   PubMedGoogle Scholar
• Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–116.
   PubMed Web of Science ®Google Scholar
• Manstein D, Herron GS, Sink RK, Tanner H, Anderson RR. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med. 2004;34:426–438.
   PubMed Web of Science ®Google Scholar
• Hantash BM, Bedi VP, Sudireddy V, Struck SK, Herron GS, Chan KF. Laser-induced transepidermal elimination of dermal content by fractional photothermolysis. J Biomed Opt. 2006;11:1–9.
   Web of Science ®Google Scholar
• Goldberg DJ, Berlin AL, Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med. 2008;40:134–138.
   PubMed Web of Science ®Google Scholar
• Laubach HJ, Tannous Z, Anderson RR, Manstein D. Skin responses to fractional photothermolysis. Lasers Surg Med. 2006;38:142–149.
   PubMed Web of Science ®Google Scholar
• Sherling M, Friedman PM, Adrian R, Burns AJ, Conn H, Fitzpatrick R, et al. Consensus recommendations on the use of an erbium doped 1550 nm fractionated laser and its applications in dermatologic laser surgery. Dermatol Surg. 2010;36:461–469.
   PubMed Web of Science ®Google Scholar
• Karsai S, Fischer T, Phol L, Schmitt L, Buhck H, Junger M, Raulin C. Is non-ablative 1550 nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients. J Eur Acad Dermatol Venereol. 2012;26:470–476.
   PubMed Web of Science ®Google Scholar
• Barysch MJ, Rummelein B, Kolm I, Karpova MB, Schonewolf N, Bogdan Allemann I, Dummer R. Split-face study of melasma patients treated with non-ablative fractionated photothermolysis (1540nm) J Eur Acad Dermatol Venereol. 2012;26:423–430.
   Google Scholar
• Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg. 2005;31:1645–1650.
   PubMed Web of Science ®Google Scholar
• Tourlaki A, Galimberti MG, Pellacani G, Bencini PL. Combination of fractional erbium glass laser and topical therapy in melasma resistant to triple-combination cream. J Dermatolog Treat. 2012 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar